Anzeige
Mehr »
Sonntag, 26.07.2026 - Börsentäglich über 12.000 News
Bergbau an Land vs. Tiefsee-Knollen: Welcher Fußabdruck siegt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
24.07.26 | 08:01
3,800 Euro
-2,56 % -0,100
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,8003,82019:04
3,7203,90024.07.

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
15.07.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
15.07.Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market2
02.07.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
15.06.Lifecore Biomedical signs manufacturing deal for neurology product1
15.06.Lifecore Biomedical schließt Produktionsvertrag für Neurologie-Präparat1
15.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company498--Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Neurology Product-- --Seventh Addition to Lifecore's Late-Stage Pipeline in Seven Months-- CHASKA, Minn., June...
► Artikel lesen
05.06.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
03.06.Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic6
02.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer1
06.05.Lifecore Biomedical Q1 2026 Earnings Call Transcript1
06.05.Lifecore Biomedical GAAP EPS of $0.43 beats by $0.72, revenue of $23.2M misses by $2.76M1
06.05.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update212-- Reaffirms 2026 Guidance -- -- Signed Three New Commercial Site Transfer Programs in First Quarter 2026 -- -- Cost Containment Initiatives Continue to Drive Down Expenses -- Conference Call Today...
► Artikel lesen
06.05.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report-
06.05.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
27.04.Laughing Water Capital's Insights on Lifecore Biomedical (LFCR)1
22.04.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
08.04.Lifecore Biomedical, Inc.: Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit1
26.03.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
26.03.Lifecore Biomedical Inks Two New Agreements with Existing US Customer2
26.03.Lifecore signs two manufacturing deals with existing customer2
Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1